Research ExplorerJournalsLUNG CANCER Publications

LUNG CANCER - Lung cancer (Amsterdam, Netherlands)

1 - 16 out of 16Page size: 50

Publications

  1. 2020

  2. Risk stratification of EGFR(+) lung cancer diagnosed with panel-based next-generation sequencing

    Christopoulos, P., Kirchner, M., Roeper, J., Saalfeld, F., Janning, M., Bozorgmehr, F., Magios, N., Kazdal, D., Volckmar, A. L., Brückner, L. M., Bochtler, T., Kriegsmann, M., Endris, V., Penzel, R., Kriegsmann, K., Eichhorn, M., Herth, F. J. F., Heussel, C. P., El Shafie, R. A., Schneider, M. A., Muley, T., Meister, M., Faehling, M., Fischer, J. R., Heukamp, L., Schirmacher, P., Bischoff, H., Wermke, M., Loges, S., Griesinger, F., Stenzinger, A. & Thomas, M., 10.2020, In: LUNG CANCER. 148, p. 105-112 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  3. 2016

  4. Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases-A pooled analysis of the German working group "stereotactic radiotherapy"

    Rieber, J., Streblow, J., Uhlmann, L., Flentje, M., Duma, M., Ernst, I., Blanck, O., Wittig, A., Boda-Heggemann, J., Krempien, R., Lohaus, F., Klass, N. D., Eble, M. J., Imhoff, D., Kahl, H., Petersen, C., Gerum, S., Henkenberens, C., Adebahr, S., Hass, P., Schrade, E., Wendt, T. G., Hildebrandt, G., Andratschke, N., Sterzing, F. & Guckenberger, M., 07.2016, In: LUNG CANCER. 97, p. 51-8 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  5. 2014

  6. Depression, anxiety and disease-related distress in couples affected by advanced lung cancer

    Haun, M. W., Sklenarova, H., Villalobos, M., Thomas, M., Brechtel, A., Löwe, B., Herzog, W. & Hartmann, M., 01.11.2014, In: LUNG CANCER. 86, 2, p. 274-280 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  7. 2013

  8. C-X-C motif receptor 2, endostatin and proteinase-activated receptor 1 polymorphisms as prognostic factors in NSCLC

    Uzunoglu, F. G., Yavari, N., Bohn, B. A., Nentwich, M. F., Reeh, M., Pantel, K., Perez, D., Tsui, T. Y., Bockhorn, M., Mann, O., Izbicki, J. R., Wikman, H. & Vashist, Y. K., 01.07.2013, In: LUNG CANCER. 81, 1, p. 123-9 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  9. CNS metastases in non-small-cell lung cancer: current role of EGFR-TKI therapy and future perspectives

    Berger, L. A., Riesenberg, H., Bokemeyer, C. & Atanackovic, D., 01.06.2013, In: LUNG CANCER. 80, 3, p. 242-8 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  10. Frequent intratumoral heterogeneity of EGFR gene copy gain in non-small cell lung cancer

    Grob, T. J., Hoenig, T., Clauditz, T. S., Atanackovic, D., Koenig, A. M., Vashist, Y. K., Klose, H., Simon, R., Pantel, K., Izbicki, J. R., Bokemeyer, C., Sauter, G. & Wilczak, W., 01.03.2013, In: LUNG CANCER. 79, 3, p. 221-7 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  11. The T393C polymorphism of GNAS1 is a predictor for relapse and survival in resectable non-small cell lung cancer.

    Uzunoglu, F. G., Heumann, A., Musici, S., Kutup, A., König, A., Roch, N., Thomssen, A., Dohrmann, T. W., Tsui, T. Y., Mann, O., Izbicki, J. R. & Vashist, Y., 2013, In: LUNG CANCER. 79, 2, p. 151-155 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  12. 2011

  13. Predicting lung cancer deaths from smoking prevalence data

    Winkler, V., Ng, N., Tesfaye, F. & Becher, H., 01.11.2011, In: LUNG CANCER. 74, 2, p. 170-7 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  14. Neuronal differentiation by indomethacin and IBMX inhibits proliferation of small cell lung cancer cells in vitro.

    Lange, A., Gustke, H., Glassmeier, G., Heine, M., Zangemeister-Wittke, U., Schwarz, J., Schumacher, U. & Lange, T., 2011, In: LUNG CANCER. 74, 2, p. 178-187 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  15. 2010

  16. Lessons learnt from gefitinib and erlotinib: Key insights into small-molecule EGFR-targeted kinase inhibitors in non-small cell lung cancer.

    Laack, H-E., Sauter, G. & Bokemeyer, C., 2010, In: LUNG CANCER. 69, 3, p. 259-264 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  17. 2009

  18. Dithiolethione modified valproate and diclofenac increase E-cadherin expression and decrease proliferation of non-small cell lung cancer cells.

    Moody, T. W., Switzer, C., Santana-Flores, W., Ridnour, L. A., Berna, M., Berna-Thill, M., Jensen, R. T., Sparatore, A., Piero, D. S., Yeh, G. C., Roberts, D. D., Giaccone, G. & Wink, D. A., 2009, In: LUNG CANCER.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  19. 2008

  20. Elevated expression of carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM-1) is associated with increased angiogenic potential in non-small-cell lung cancer.

    Dango, S., Sienel, W., Schreiber, M., Stremmel, C., Kirschbaum, A., Pantel, K. & Passlick, B., 2008, In: LUNG CANCER. 60, 3, p. 426-433 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  21. Phase II study of plitidepsin in pretreated patients with locally advanced or metastatic non-small cell lung cancer.

    Peschel, C., Hartmann, J. T., Schmittel, A., Bokemeyer, C., Schneller, F., Keilholz, U., Buchheidt, D., Millan, S., Izquierdo, M. A. & Hofheinz, R-D., 2008, In: LUNG CANCER. 60, 3, p. 374-380 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  22. 2007

  23. A phase II study of irinotecan (CPT-11) and carboplatin in patients with limited disease small cell lung cancer (SCLC).

    Laack, E., Thoem, I., Krüll, A., Engel-Riedel, W., Müller, T., Meissner, C., Dürk, H., Fischer, J., Gütz, S., Kortsik, C., Elbers, M., Schuch, G., Andritzky, B., Görn, M., Burkholder, I., Edler, L., Hossfeld, D. K. & Bokemeyer, C., 2007, In: LUNG CANCER. 57, 2, p. 181-186 2.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  24. Lectin histochemistry of metastatic adenocarcinomas of the lung.

    Thoem, I., Schult-Kronefeld, O., Burkholder, I., Goern, M., Andritzky, B., Blonski, K., Kugler, C., Edler, L., Bokemeyer, C., Schumacher, U. & Laack, E., 2007, In: LUNG CANCER. 56, 3, p. 391-397 3.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  25. 2005

  26. Serum levels of Magic Roundabout protein in patients with advanced non-small cell lung cancer (NSCLC).

    Görn, M., Anige, M., Burkholder, I., Müller, B., Scheffler, A., Edler, L., Boeters, I., Panse, J., Schuch, G., Hossfeld, D. K. & Laack, E., 2005, In: LUNG CANCER. 49, 1, p. 71-76 1.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review